Biomarin Pharmaceutical Inc (BMRN) Insider Trading

Total insider buys:
  • $1,316,196.75
Total insider sells:
  • $342,139,664.94
Most recent insider trade:
  • Nov. 12, 2024
Most active insider trader:
  • Jean Jacques Bienaime
Trader NameDateTitleAmountPriceTypeTotal Value
July 27, 2016Director1,100$95.39Sell$104,929.00
July 22, 2016Director6,400$95.01Sell$608,064.00
July 18, 2016CEO41,666$92.72Sell$3,863,271.52
July 7, 2016EVP2,167$90.00Sell$195,030.00
June 20, 2016Director550$82.77Sell$45,523.50
June 16, 2016CEO41,666$80.55Sell$3,356,196.30
June 6, 2016CFO1,649$89.14Sell$146,991.86
May 31, 2016CFO20,841$89.88Sell$1,873,189.08
May 26, 2016EVP15,000$87.81Sell$1,317,150.00
May 23, 2016CFO3,769$87.07Sell$328,166.83
May 18, 2016EVP5,000$87.05Sell$435,250.00
May 10, 2016EVP14,658$85.11Sell$1,247,542.38
May 5, 2016CEO50,000$80.15Sell$4,007,500.00
May 3, 2016EVP415$86.03Sell$35,702.45
May 2, 2016CEO36,500$85.01Sell$3,102,865.00
March 14, 2016EVP1,996$86.21Sell$172,075.16
March 4, 2016SVP1,255$88.42Sell$110,967.10
March 2, 2016CFO4,623$86.12Sell$398,132.76
March 1, 2016CEO10,000$84.28Sell$842,800.00
Feb. 22, 2016Director7,500$80.00Sell$600,000.00
Dec. 16, 2015SVP1,362$100.00Sell$136,200.00
Nov. 30, 2015CEO1,000$94.74Sell$94,740.00
Nov. 16, 2015Director8,550$106.90Sell$913,995.00
Nov. 16, 2015CFO20,000$104.30Sell$2,086,000.00
Oct. 15, 2015CEO1,000$108.24Sell$108,240.00
Sept. 14, 2015CEO1,000$131.43Sell$131,430.00
July 20, 2015SVP3,000$150.00Sell$450,000.00
July 7, 2015CEO1,500$139.07Sell$208,605.00
June 5, 2015EVP1,864$122.32Sell$228,004.48
June 5, 2015CFO1,649$122.30Sell$201,672.70
June 4, 2015SVP1,362$122.35Sell$166,640.70
June 1, 2015SVP377$123.76Sell$46,657.52
June 1, 2015CFO5,523$124.73Sell$688,883.79
May 29, 2015CFO1,578$126.15Sell$199,064.70
May 26, 2015SVP1,625$126.55Sell$205,643.75
May 18, 2015CFO2,059$124.77Sell$256,901.43
May 18, 2015SVP2,558$125.26Sell$320,415.08
May 18, 2015EVP1,864$124.78Sell$232,589.92
May 13, 2015EVP1,434$121.37Sell$174,044.58
May 11, 2015EVP2,869$121.64Sell$348,985.16
March 17, 2015CEO2,000$124.17Sell$248,340.00
March 16, 2015EVP41,315$123.57Sell$5,105,294.55
March 16, 2015CEO1,000$123.48Sell$123,480.00
March 10, 2015CEO21,021$112.39Sell$2,362,550.19
March 9, 2015CEO19,000$112.13Sell$2,130,470.00
March 5, 2015EVP14,051$116.37Sell$1,635,114.87
March 5, 2015CEO10,000$113.70Sell$1,137,000.00
March 4, 2015CEO13,916$107.92Sell$1,501,814.72
March 3, 2015CEO5,000$107.42Sell$537,100.00
March 2, 2015CFO15,500$107.00Sell$1,658,500.00
  • Insiders are both buying and selling Biomarin Pharmaceutical Inc stock.

  • The insider traders at Biomarin Pharmaceutical Inc are: Jean Jacques Bienaime, Jeffrey Robert Ajer, George Eric Davis, Henry J Fuchs, Daniel K Spiegelman, V Bryan Lawlis, Brian Mueller, Robert Baffi, Henry Fuchs, Mark Wood, Richard A Meier, Michael G Grey, Alan Lewis, Charles Greg Guyer, Elaine J Heron, Henry J. Fuchs, Mark J Alles, Erin Burkhart, Dennis Slamon, Mueller Brian, Davis George Eric, David E I Pyott, Daniel K. Spiegelman, and Willard H Dere

  • The most active insider trader at Biomarin Pharmaceutical Inc is Jean Jacques Bienaime with 153 trades.

  • Jean Jacques Bienaime has sold the most Biomarin Pharmaceutical Inc stock with a total value of $179,727,061.76.

  • David E I Pyott has bought the most Biomarin Pharmaceutical Inc stock with a total value of $2,003,456.00.

  • The most recent insider trade for Biomarin Pharmaceutical Inc was on Nov. 12, 2024.

  • The single biggest insider buy for Biomarin Pharmaceutical Inc was from David E I Pyott with a total value of $1,001,728.00 on Aug. 31, 2020.

  • The single biggest insider sell for Biomarin Pharmaceutical Inc was from Henry J Fuchs with a total value of $16,430,570.00 on July 20, 2020.